About Accelovance
Accelovance is a company based in Rockville (United States) founded in 2005 was acquired by Linical in March 2018.. Accelovance has raised $4 million across 3 funding rounds from investors including European Union and Linical. Accelovance has completed 2 acquisitions, including Altairclinical and Ntouch Research. Accelovance operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
- Headquarter Rockville, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4 M (USD)
in 3 rounds
-
Latest Funding Round
$545.04 K (USD), Grant
Sep 01, 2015
-
Investors
European Union
& 1 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Altairclinical
& 1 more
-
Acquired by
Linical
(Mar 27, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Accelovance
Accelovance has successfully raised a total of $4M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $545.04 thousand completed in September 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $545,040
-
First Round
First Round
(21 Dec 2005)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2015 | Amount | Grant - Accelovance | Valuation |
investors |
|
| May, 2015 | Amount | Grant - Accelovance | Valuation |
investors |
|
| Dec, 2005 | Amount | Series A - Accelovance | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Accelovance
Accelovance has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Linical. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Full-service CRO operations are conducted across more than 20 countries.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Accelovance
Accelovance has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Altairclinical and Ntouch Research. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Full service CRO
|
1997 | ||||
|
Clinical services are provided through Altair Clinical's platform.
|
0 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Accelovance
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Accelovance Comparisons
Competitors of Accelovance
Accelovance operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for cancer and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
CRO clinical development services are provided by Syneos Health.
|
|
| domain | founded_year | HQ Location |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| domain | founded_year | HQ Location |
Outsourced contract research organization services are provided to clients.
|
|
| domain | founded_year | HQ Location |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| domain | founded_year | HQ Location |
Global full-service CRO services are delivered in over 80 countries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Accelovance
Frequently Asked Questions about Accelovance
When was Accelovance founded?
Accelovance was founded in 2005.
Where is Accelovance located?
Accelovance is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Is Accelovance a funded company?
Accelovance is a funded company, having raised a total of $4M across 3 funding rounds to date. The company's 1st funding round was a Series A of $4M, raised on Dec 21, 2005.
What does Accelovance do?
Accelovance is a full service CRO offering a wide range of services for Phase I to IV trials. Their offerings are protocol management, project and data management, clinical trial monitoring, biostatistics, patient recruitment, regulatory affairs, pharmacovilgilance, medical writing etc., Its Clinical Call Center helps them in managing patient recruitment, retention, compliance, surveillance or safety. Accelovances Elite Monitoring service offers flexible staffing solutions based on customer requirements. Their offerings are catered to oncology, vaccines and general medicine which includes cardiovascular, dermatology, nutrition, urology, and womens health. It has offices in North America, Europe and China and partnerships in India, Asia Pacific and South America.
Who are the top competitors of Accelovance?
Accelovance's top competitors include Emmes, Syneos Health and ClinChoice.
How many acquisitions has Accelovance made?
Accelovance has made 2 acquisitions, including Altairclinical, and Ntouch Research.
Who are Accelovance's investors?
Accelovance has 2 investors. Key investors include European Union, and Linical.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.